Page last updated: 2024-10-27

fluconazole and Bilharziasis

fluconazole has been researched along with Bilharziasis in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Schistosomiasis is a chronic disease caused by blood flukes of the Schistosoma spp."1.72Fluconazole as Schistosoma mansoni cytochrome P450 inhibitor: In vivo murine experimental study. ( Aboukamar, WA; El-Gamal, R; Elhenawy, AA; Elmehankar, MS; Elzoheiry, MA; Nabih, N; Sheta, H; Zenezan, D, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Elzoheiry, MA1
Elmehankar, MS1
Aboukamar, WA1
El-Gamal, R1
Sheta, H1
Zenezan, D1
Nabih, N1
Elhenawy, AA1

Other Studies

1 other study available for fluconazole and Bilharziasis

ArticleYear
Fluconazole as Schistosoma mansoni cytochrome P450 inhibitor: In vivo murine experimental study.
    Experimental parasitology, 2022, Volume: 239

    Topics: Animals; Cytochrome P-450 Enzyme System; Fluconazole; Mice; Schistosoma mansoni; Schistosomiasis; Sc

2022